Related Experiment Video
Updated: Oct 5, 2025
Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Anti-citrullinated Protein Antibody Generation, Pathogenesis, Clinical Application, and Prospects
Jiaxi Liu1, Jinfang Gao1, Zewen Wu1
1Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Tongji Shanxi Hospital, Shanxi Academy of Medical Sciences, Taiyuan, China.
Abstract:
Anti-citrullinated protein antibodies (ACPAs) are autoantibodies commonly observed in patients with rheumatoid arthritis (RA). Currently, most of the mechanisms of ACPA formation and bone destruction are well-understood, however, some unknown mechanisms still exist. There have been many new advances in ACPA-related clinical applications and targeted therapies. However, the existence of different ACPA subtypes is a limitation of targeted therapy. Herein, we present an overview of the process of ACPA generation, the underlying pathogenesis, and relevant clinical application and prospects.
Insights
Anti-citrullinated protein antibodies (ACPAs) are key in rheumatoid arthritis (RA). This review covers ACPA generation, pathogenesis, and clinical applications, highlighting challenges in targeted therapy due to ACPA subtypes.
Area of Science:
- Rheumatology
- Immunology
- Autoimmunity
Background:
- Rheumatoid arthritis (RA) is often associated with anti-citrullinated protein antibodies (ACPAs).
- While ACPA formation and bone destruction mechanisms are largely understood, some aspects remain unclear.
- Advances in ACPA-related therapies and clinical applications are ongoing.
Purpose of the Study:
- To provide a comprehensive overview of anti-citrullinated protein antibody (ACPA) generation.
- To elucidate the underlying pathogenesis of ACPA-related bone destruction.
- To discuss current clinical applications and future prospects for ACPA-targeted therapies.
Main Methods:
- Literature review of ACPA generation.
- Analysis of pathogenic mechanisms in rheumatoid arthritis.
- Evaluation of clinical applications and therapeutic strategies for ACPA.
Main Results:
- Detailed explanation of ACPA generation pathways.
- Identification of known and unknown mechanisms in RA pathogenesis.
- Discussion of therapeutic limitations due to ACPA heterogeneity.
Conclusions:
- Understanding ACPA generation and pathogenesis is crucial for RA treatment.
- ACPA subtypes present a significant challenge for targeted therapy development.
- Further research into ACPA heterogeneity may unlock more effective RA treatments.
Related Concept Videos
01:17Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF